Lv31
270 积分 2025-06-24 加入
Impact of resumption of Oral AntiCoagulation therapy (OAC) after GastroIntestinal Bleeding (GIB) on clinical outcomes in patients with Non-Valvular Atrial Fibrillation (NVAF)
2个月前
已完结
Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients
2个月前
已完结
“I Didn't Know I Had a Choice” - Patient Values and Preferences Regarding Resumption of Oral Anticoagulants after Gastrointestinal Bleeding
2个月前
已完结
Restarting Anticoagulation After Major Bleeding in Patients With Atrial Fibrillation
2个月前
已完结
AASLD ISDA Practice Guideline on treatment of chronic hepatitis B
3个月前
已完结
2025 ESC/EACTS Guidelines for the management of valvular heart disease
3个月前
已完结
Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data
5个月前
已完结
Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study
5个月前
已完结
On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillation
6个月前
已完结
Perioperative Management of Patients Taking Direct Oral Anticoagulants
6个月前
已完结
皖公网安备34019202002308
